急性 COVID-19 疾病背景下的严重快速进展性吉兰-巴雷综合征。
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
机构信息
Division of Neuromuscular Diseases and Clinical Neurophysiology Laboratories, Department of Neurology, Icahn School of Medicine, Mount Sinai Hospital, 1468 Madison Avenue, New York, NY, 10029, USA.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
J Neurovirol. 2020 Oct;26(5):797-799. doi: 10.1007/s13365-020-00884-7. Epub 2020 Jul 27.
Abstract
There is concern that the global burden of coronavirus disease of 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection might yield an increased occurrence of Guillain-Barré syndrome (GBS). It is currently unknown whether concomitant SARS-CoV-2 infection and GBS are pathophysiologically related, what biomarkers are useful for diagnosis, and what is the optimal treatment given the medical comorbidities, complications, and simultaneous infection. We report a patient who developed severe GBS following SARS-CoV-2 infection at the peak of the initial COVID-19 surge (April 2020) in New York City and discuss diagnostic and management issues and complications that may warrant special consideration in similar patients.
摘要
人们担心，由严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）感染引起的 2019 年冠状病毒病（COVID-19）全球负担可能导致格林-巴利综合征（GBS）的发生率增加。目前尚不清楚同时发生的 SARS-CoV-2 感染和 GBS 是否与病理生理学有关，哪些生物标志物有助于诊断，以及鉴于合并症、并发症和同时感染，最佳治疗方法是什么。我们报告了一名患者，他在纽约市 COVID-19 首次爆发高峰期（2020 年 4 月）感染 SARS-CoV-2 后出现严重 GBS，并讨论了诊断和管理问题以及并发症，这些问题可能需要在类似患者中特别考虑。
相似文献
1
Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
J Neurovirol. 2020 Oct;26(5):797-799. doi: 10.1007/s13365-020-00884-7. Epub 2020 Jul 27.
2
Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
Neuromuscul Disord. 2020 Oct;30(10):859-861. doi: 10.1016/j.nmd.2020.08.354. Epub 2020 Aug 12.
3
Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):510-513. doi: 10.1093/jpids/piaa086.
4
A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Arch Iran Med. 2020 Oct 1;23(10):718-721. doi: 10.34172/aim.2020.93.
5
SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
J Clin Neuromuscul Dis. 2020 Sep;22(1):58-59. doi: 10.1097/CND.0000000000000310.
6
Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
J Clin Neurosci. 2020 Jul;77:230-232. doi: 10.1016/j.jocn.2020.05.016. Epub 2020 May 14.
7
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1105-1110. doi: 10.1136/jnnp-2020-324491. Epub 2020 Aug 27.
8
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
Acta Neurol Belg. 2020 Oct;120(5):1067-1075. doi: 10.1007/s13760-020-01421-3. Epub 2020 Jul 21.
9
Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
J Peripher Nerv Syst. 2020 Jun;25(2):204-207. doi: 10.1111/jns.12382. Epub 2020 May 26.
10
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
Neurologia (Engl Ed). 2020 May;35(4):265-267. doi: 10.1016/j.nrl.2020.04.004. Epub 2020 Apr 18.
引用本文的文献
1
Evaluating algorithms for identifying incident Guillain-Barré Syndrome in Medicare fee-for-service claims.
Glob Epidemiol. 2024 May 3;7:100145. doi: 10.1016/j.gloepi.2024.100145. eCollection 2024 Jun.
2
Bradycardia unresponded to atropin testing was successfully treated with therapeutic plasma exchange in a patient with severe COVID-19 complicated by Guillain-Barré syndrome: A case report.
Front Cardiovasc Med. 2023 Jan 19;9:1035896. doi: 10.3389/fcvm.2022.1035896. eCollection 2022.
3
Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review.
Heliyon. 2022 Nov;8(11):e11328. doi: 10.1016/j.heliyon.2022.e11328. Epub 2022 Nov 1.
4
Guillain-Barré Syndrome in Patient With SARS-CoV-2 PCR Positivity Treated Successfully With Therapeutic Exchange Plasma: A First Case Report From Vietnam.
Front Neurol. 2022 May 25;13:868667. doi: 10.3389/fneur.2022.868667. eCollection 2022.
5
Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.
J Clin Neurosci. 2022 Jul;101:264-275. doi: 10.1016/j.jocn.2022.03.048. Epub 2022 Apr 29.
6
Demographic, Clinical, and Investigational Characteristics of COVID-19- related Guillain-Barré Syndrome with Differences from Typical and Another Virus-related Guillain-Barré Syndrome.
Infect Disord Drug Targets. 2022;22(7):27-38. doi: 10.2174/1871526522666220429134113.
7
COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.
J Peripher Nerv Syst. 2022 Mar;27(1):4-30. doi: 10.1111/jns.12482. Epub 2022 Mar 14.
8
Guillain-Barré Syndrome in the COVID-19 Pandemic.
Neurol Int. 2021 Dec 24;14(1):34-48. doi: 10.3390/neurolint14010003.
9
Online News Coverage of COVID-19 Long Haul Symptoms.
J Community Health. 2022 Apr;47(2):306-310. doi: 10.1007/s10900-021-01053-5. Epub 2021 Dec 3.
10
COVID-19 infection presented as Guillain-Barre Syndrome: Report of two new cases and review of 116 reported cases and case series.
Travel Med Infect Dis. 2021 Nov-Dec;44:102169. doi: 10.1016/j.tmaid.2021.102169. Epub 2021 Oct 6.
本文引用的文献
1
Guillain-Barré syndrome following COVID-19: new infection, old complication?
J Neurol. 2020 Jul;267(7):1877-1879. doi: 10.1007/s00415-020-09849-6. Epub 2020 Apr 24.
2
Guillain Barre syndrome associated with COVID-19 infection: A case report.
J Clin Neurosci. 2020 Jun;76:233-235. doi: 10.1016/j.jocn.2020.04.062. Epub 2020 Apr 15.
3
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
4
Challenges of Convalescent Plasma Therapy on COVID-19.
J Clin Virol. 2020 Jun;127:104358. doi: 10.1016/j.jcv.2020.104358. Epub 2020 Apr 10.
5
Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
Neurology. 2020 Aug 4;95(5):e601-e605. doi: 10.1212/WNL.0000000000009619. Epub 2020 Apr 17.
6
Guillain-Barré Syndrome Associated with SARS-CoV-2.
N Engl J Med. 2020 Jun 25;382(26):2574-2576. doi: 10.1056/NEJMc2009191. Epub 2020 Apr 17.
7
COVID-19 and neuromuscular disorders.
Neurology. 2020 Jun 2;94(22):959-969. doi: 10.1212/WNL.0000000000009566. Epub 2020 Apr 13.
8
Hematological findings and complications of COVID-19.
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
9
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
Lancet Neurol. 2020 May;19(5):383-384. doi: 10.1016/S1474-4422(20)30109-5. Epub 2020 Apr 1.
10
Safety of Therapeutic Plasma Exchange for the Treatment of Guillain-Barré Syndrome in Polycythemia Vera.
Neurologist. 2018 Nov;23(6):185-187. doi: 10.1097/NRL.0000000000000197.
Zotero 插件